Kisicki, Abby
Becker, Sara
Chaple, Michael
Gustafson, David H.
Hartzler, Bryan J.
Jacobson, Nora
Murphy, Ann A.
Tapscott, Stephanie
Molfenter, Todd
Funding for this research was provided by:
Substance Abuse and Mental Health Services Administration (H79SM081733, UR1TI080209, UR1TI082504, R01DS044159, UR1TI080201, H79SM081733, H79SM081783, H79SM081774, H79SM081733)
Article History
Received: 12 October 2021
Accepted: 19 May 2022
First Online: 13 June 2022
Declarations
:
: The University of Wisconsin Health Sciences Minimal Risk Institutional Review Board deemed this research as being exempt human subjects research as defined under 45 CFR 46, thus waiving the need for participant consent (ID#: 2020–0551). Despite this exemption, all participants were nonetheless informed that the survey was voluntary in the email solicitation to complete the survey. All methods were carried out in accordance with the relevant guidelines and regulations.
: This is not applicable as there are no personal identifiers present in the dataset.
: Author Molfenter has < 1% stock ownership in CHESS Mobile Health. CHESS Mobile Health does not provide or facilitate telephonic or video care delivery. Dr. Molfenter has worked extensively with his institution to manage any conflicts of interest. No other authors have competing interests regarding this manuscript.